| 英文名称 |
PL-A’:(1R,3aR,7aR)-1-((2R,5R,E)-6-hydroxy-5,6-dimethy lhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one PL-AS’:(1R,3aR,7aR)-1-((2R,5R,Z)-6-hydroxy-5,
|
| 英文别名 |
Paricalcitol-5;(1R,3aR,7aR)-1-((2R,5R,E)-6-hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one;4H-Inden-4-one, octahydro-1-(5-hydroxy-1,4,5-trimethyl-2-hexenyl)-7a-methyl-, [1R-[1α(1R*,2E,4R*),3aβ,7aα;PL-A’:(1R,3aR,7aR)-1-((2R,5R,E)-6-hydroxy-5,6-dimethy lhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one PL-AS’:(1R,3aR,7aR)-1-((2R,5R,Z)-6-hydroxy-5,
|
| 详情描述 |
仅用于研发试验中鉴别、检查。139238-89-4|帕立骨化醇杂质A' AS'对照品(PL-A'),制备中,详情请联系Medlife客服进行咨询。PL-A’:(1R,3aR,7aR)-1-((2R,5R,E)-6-hydroxy-5,6-dimethy lhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one PL-AS’:(1R,3aR,7aR)-1-((2R,5R,Z)-6-hydroxy-5,可放大生产,批量保障。
|